Summary:
Evans' syndrome, a combination of autoimmune haemolytic anaemia and autoimmune (idiopathic) thrombocytopenic purpura, is generally harder to treat and more refractory than the single entities. In a male patient with refractory disease, predominantly thrombocytopenic, an allogeneic reduced intensity BMT from his human leukocyte antigen (HLA)-identical sister was followed by a dramatic platelet peak while he was still experiencing initial engraftment (presumably of autologous origin), but subsequently by progressive relapse associated with mixed chimerism. Five gradually incremental DLI achieved complete donor chimerism, which was associated not only with grade II graft-versus-host disease (GVHD), but also with complete clinical and biological remission for 2 years post-transplant. Long-term FU is necessary before claiming that allogeneic stem cell transplantation (SCT) is capable of curing an autoimmune blood disease. However, there is evidence for a graft-versus-autoimmunity effect in this case.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Evans RS, Takahashi K, Duane RT et al. Primary thrombocytopenic purpura and acquired haemolytic anemia. Evidence for a common etiology. Arch Intern Med 1951; 87: 48–65.
Savasan S, Warrier I, Ravindranath Y . The spectrum of Evans' syndrome. Arch Dis Child 1997; 77: 245–248.
Portilje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A . Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549–2554.
Oyama Y, Papadopoulos EB, Miranda M et al. Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant 2001; 28: 903–905.
Marmont AM . Immune ablation and stem cell transplantation for severe Evans syndrome and refractory thrombocytopenic purpura. Bone Marrow Transplant 1999; 23: 1215–1216.
Musso M, Porretto F, Crescimanno A et al. Autologous peripheral blood stem and progenitor cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998; 7: 492–494.
Skoda RC, Tichelli A, Tyndall A et al. Autologous peripheral blood stem cell transplantation in refractory thrombocytopenic purpura. Br J Haematol 1997; 99: 56–57.
Marmont AM, van Lint MT, Occhini D et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura. Bone Marrow Transplant 1998; 22: 227–228.
Lim SH, Kell J, Al-Sabah A et al. Peripheral blood stem cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997; 340: 475 (letter).
Gratwohl A, Passweg J, Gerber I, Tyndall A . Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Hematol 2001; 14: 755–776.
Fogarty PF, Huhn RD, Nakamura R et al. Intensive immunosuppression with high-dose cyclophosphamide and autologous CD34+ selected hematopoietic cell support for chronic refractory autoimmune thrombocytopenia (AITP): a follow-up report. Blood 2001; 98: 442 (abstract).
Zaydan MA, Turner C, Miller AM . Resolution of chronic idiopathic thrombocytopenia purpura following syngeneic peripheral blood progenitor transplant. Bone Marrow Transplant. 2002; 29: 87–89.
Raetz E, Beatty PG, Adams RHO . Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant 1997; 20: 427–429.
Couzin J . Gently soothing a savage immune system. Science 2002; 296: 456–458.
Di Stefano P, Zecca M, Giorgiani G et al. Resolution of immune haemolytic anemia with allogeneic bone marrow transplantation after unsuccessful autograft. Br J Haematol 1999; 106: 1063–1064.
McColl G, Kushaka H, Wicks I . High-dose chemotherapy and syngeneic hemopoietic stem cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 1999; 131: 550–553.
Antin JH, Childs R, Filipovich AH et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001; 7: 473–485.
Dominietto A, Raiola AM, van Lint MT et al. Factors influencing haematological recovery after allogeneic haematopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 2001; 112: 219–227.
McMillan R . Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol 2000; 37: 239–248.
Marmont AM . New horizons in the treatment of autoimmune disease: immunoablation and stem cell transplantation. Annu Rev Med 2000; 51: 115–134.
Li H, Kaufman CL, Boggs SS et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 1996; 156: 380–387.
Seung E, Iwakoshi N, Woda BA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus host disease induction, of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175–2182.
Slavin S, Nagler A, Varadi G, Or R . Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853–857.
Hinterberger W, Hinterberger-Fischer M, Marmont AM . Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favourably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 733–759.
Dickinson A, Carr A . Haemopoietic stem cell transplantation: improving immune reconstitution, avoiding graft-versus-host disease. Lancet 2002; 360: 98–99.
Burt RK, Slavin S, Burns WH, Marmont AM . Induction of tolerance in autoimmune diseases by haematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768–782.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marmont, A., Gualandi, F., van Lint, M. et al. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 31, 399–402 (2003). https://doi.org/10.1038/sj.bmt.1703833
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703833
Keywords
This article is cited by
-
Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation
Bone Marrow Transplantation (2015)
-
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation
Bone Marrow Transplantation (2012)
-
Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis
Immunologic Research (2008)
-
Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease?
Bone Marrow Transplantation (2007)
-
Split chimerism may be enough to cure Evans syndrome
Bone Marrow Transplantation (2006)